AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?

Author： van der Laan Luc JW   Wang Yigang   Tilanus Hugo W   Janssen Harry LA   Pan Qiuwei  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.11, Iss.3, 2011-03, pp. : 315-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chromosomal position effects on AAV-mediated gene targeting

By Cornea Anda M.  

Nucleic Acids Research, Vol. 38, Iss. 11, 2010-06 ,pp. : 3582-3594

Oxford University Press

Access to resources Recommend Favorite

Gene therapy of liver diseases

By Prieto Jesus   Qian Cheng   Hernandez-Alcoceba Ruben   Gonzalez-Aseguinolaza Gloria   Mazzolini Guillermo   Sangro Bruno   Kramer M Gabriela  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 7, 2004-07 ,pp. : 1073-1091

Informa Healthcare

Access to resources Recommend Favorite

AAV-directed muscular dystrophy gene therapy

By Tang Ying   Cummins James   Huard Johnny   Wang Bing  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 395-408

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy of gynaecological diseases

By Kanerva Anna   Raki Mari   Hemminki Akseli  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 9, 2007-09 ,pp. : 1347-1361

Informa Healthcare

Access to resources Recommend Favorite

Novel candidate disease for gene therapy: metachromatic leukodystrophy

By Biffi Alessandra   Naldini Luigi  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 8, 2007-08 ,pp. : 1193-1205

Informa Healthcare

Access to resources Recommend Favorite